Shokry et al., 2014 - Google Patents
Potential of camel-derived haemoglobin oxygen carriers as a blood substitute.Shokry et al., 2014
View PDF- Document ID
- 6785813830558146251
- Author
- Shokry M
- Prince A
- Attia M
- Ibrahim I
- Farghalli H
- Tohamy A
- Mostafa A
- Publication year
External Links
Snippet
Camel-derived haemoglobin O2 carriers (CHBOC) are being developed as a blood substitutes for allogeneic RBCs or to improve tissue oxygenation. The tolerability of the developed product was evaluated in 10 moderately exsanguinated (40%) experimental …
- 241000282836 Camelus dromedarius 0 title abstract description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9498537B2 (en) | Method of enhancing efficacy of blood transfusions | |
| Klein et al. | Red blood cell transfusion in clinical practice | |
| ES2032802T5 (en) | SUCEDANEO OF EXTRAPUR SEMISINTETIC BLOOD. | |
| Ilesanmi | Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy | |
| JP5149480B2 (en) | Methods and compositions for oxygen transport comprising high oxygen affinity modified hemoglobin | |
| TWI377947B (en) | A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof | |
| EP1874341A1 (en) | Erythrocytes containing arginine deiminase | |
| CN111406737A (en) | Compositions, devices and methods for continuous organ maintenance | |
| Huggins | Frozen blood | |
| JP4581110B2 (en) | Purification method of hemoglobin | |
| Chang | Nanobiotechnology for hemoglobin-based blood substitutes | |
| Inayat et al. | Oxygen carriers: a selected review | |
| Tanhehco | Red blood cell transfusion | |
| Shokry et al. | Potential of camel-derived haemoglobin oxygen carriers as a blood substitute. | |
| CN113365642A (en) | Methods for controlling adverse events in inflammatory patients | |
| Ikegawa et al. | Effects of exchange transfusion with liposome‐encapsulated hemoglobin on VO2/DO2 | |
| Shokry | Hematology & Hemotherapy Journal | |
| Dracker | The development and use of oxygen-carrying blood substitutes | |
| US20240294609A1 (en) | Stabilized hemoglobin compositions and pharmaceutical formulations thereof | |
| Ikeda et al. | Cellular-type hemoglobin-based oxygen carrier as a resuscitative fluid for hemorrhagic shock: Acute and long-term safety evaluation using beagle dogs | |
| Standl | Artificial oxygen carriers as red blood cell substitutes–perfluorocarbons and cell-free hemoglobin | |
| Waschke et al. | Modified haemoglobins and perfluorocarbons | |
| Chang | A brief history of the development of nanobiotechnology-based blood substitutes | |
| Hagisawa et al. | Artificial blood transfusion | |
| RU2308279C1 (en) | Method for preparation of raw materials for production of medicines from blood |